The company manufactures and supplies value-added aluminium products like alloyed ingots, billets, and specialized components such as EV battery housings for automotive, construction, and industrial clients.
The company claims a moat through technical expertise in high-strength 2xxx and 7xxx series alloys, but the financials show a low net margin of 4.5% and a negative cash conversion of -0.86, suggesting it operates as a price-taking commodity processor rather than a specialized manufacturer with pricing power.
Earnings and IPO proceeds have been primarily directed toward expanding manufacturing capacity and working capital; however, the negative cash conversion indicates that growth is consuming more cash than the business generates, leading to a reliance on external financing.
The company's aggressive revenue growth proved to be a mirage of profitless prosperity. By 2029, the negative cash conversion cycle finally broke the balance sheet as the business was forced to borrow heavily just to fund its own bloated receivables and inventory. The massive gap between top-line expansion and bottom-line earnings revealed a complete lack of operating leverage, and as global commodity prices fluctuated, the razor-thin 4.5% margins evaporated, leaving the company as a debt-laden commodity processor with no pricing power to pass on rising import costs.
RichFakir rates Sharvaya Metals Ltd's business quality as mediocre — 42/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Sharvaya Metals Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Sharvaya Metals Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Sharvaya Metals Ltd's fair value is about ₹86 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →